Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C22H22N2O5S |
| Molecular Weight | 426.485 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1(C)S[C@@H]2[C@H](NC(=O)C(OC3=CC=CC=C3)C4=CC=CC=C4)C(=O)N2[C@H]1C(O)=O
InChI
InChIKey=VZPPEUOYDWPUKO-MQWDNKACSA-N
InChI=1S/C22H22N2O5S/c1-22(2)17(21(27)28)24-19(26)15(20(24)30-22)23-18(25)16(13-9-5-3-6-10-13)29-14-11-7-4-8-12-14/h3-12,15-17,20H,1-2H3,(H,23,25)(H,27,28)/t15-,16?,17+,20-/m1/s1
| Molecular Formula | C22H22N2O5S |
| Molecular Weight | 426.485 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [PHENOXYBENZYLPENICILLIN (PHENBENICILLIN) AND ITS MICROBIOLOGICAL STUDY]. | 1964-01 |
|
| Phenoxybenzylpenicillin in general practice. | 1963-06 |
|
| [Phenoxybenzylpenicillin]. | 1962-04-30 |
|
| Bacteriological and pharmacological properties of phenoxybenzylpenicillin. | 1962-01-13 |
|
| Bacteriological and clinical studies with phenoxybenzylpenicillin. | 1962-01-13 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13876963
125 mg six-hourly
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:27:39 GMT 2025
by
admin
on
Mon Mar 31 18:27:39 GMT 2025
|
| Record UNII |
641EDA6X6L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1500
Created by
admin on Mon Mar 31 18:27:39 GMT 2025 , Edited by admin on Mon Mar 31 18:27:39 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB07542MIG
Created by
admin on Mon Mar 31 18:27:39 GMT 2025 , Edited by admin on Mon Mar 31 18:27:39 GMT 2025
|
PRIMARY | |||
|
100000081244
Created by
admin on Mon Mar 31 18:27:39 GMT 2025 , Edited by admin on Mon Mar 31 18:27:39 GMT 2025
|
PRIMARY | |||
|
DTXSID601043196
Created by
admin on Mon Mar 31 18:27:39 GMT 2025 , Edited by admin on Mon Mar 31 18:27:39 GMT 2025
|
PRIMARY | |||
|
m1156
Created by
admin on Mon Mar 31 18:27:39 GMT 2025 , Edited by admin on Mon Mar 31 18:27:39 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL2106298
Created by
admin on Mon Mar 31 18:27:39 GMT 2025 , Edited by admin on Mon Mar 31 18:27:39 GMT 2025
|
PRIMARY | |||
|
1926-48-3
Created by
admin on Mon Mar 31 18:27:39 GMT 2025 , Edited by admin on Mon Mar 31 18:27:39 GMT 2025
|
PRIMARY | |||
|
3221
Created by
admin on Mon Mar 31 18:27:39 GMT 2025 , Edited by admin on Mon Mar 31 18:27:39 GMT 2025
|
PRIMARY | |||
|
71107
Created by
admin on Mon Mar 31 18:27:39 GMT 2025 , Edited by admin on Mon Mar 31 18:27:39 GMT 2025
|
PRIMARY | |||
|
641EDA6X6L
Created by
admin on Mon Mar 31 18:27:39 GMT 2025 , Edited by admin on Mon Mar 31 18:27:39 GMT 2025
|
PRIMARY | |||
|
C65639
Created by
admin on Mon Mar 31 18:27:39 GMT 2025 , Edited by admin on Mon Mar 31 18:27:39 GMT 2025
|
PRIMARY | |||
|
1377
Created by
admin on Mon Mar 31 18:27:39 GMT 2025 , Edited by admin on Mon Mar 31 18:27:39 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |